| First Author | Zarrinpashneh E | Year | 2008 |
| Journal | Biochem Biophys Res Commun | Volume | 376 |
| Issue | 4 | Pages | 677-81 |
| PubMed ID | 18812163 | Mgi Jnum | J:143091 |
| Mgi Id | MGI:3822921 | Doi | 10.1016/j.bbrc.2008.09.057 |
| Citation | Zarrinpashneh E, et al. (2008) AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol. Biochem Biophys Res Commun 376(4):677-81 |
| abstractText | As AMP-activated protein kinase (AMPK) controls protein translation, an anti-hypertrophic effect of AMPK has been suggested. However, there is no genetic evidence to confirm this hypothesis. We investigated the contribution of AMPKalpha2 in the control of cardiac hypertrophy by using AMPKalpha2-/- mice submitted to isoproterenol. The isoproterenol-induced cardiac hypertrophy, measured by left ventricular mass and histological examination, was significantly higher in AMPKalpha2-/- than in WT animals. Moreover, the intensification of cardiac hypertrophy found in AMPKalpha2-/- mice can be linked to the abnormal basal overstimulation of the p70 ribosomal S6 protein kinase, an enzyme known to regulate protein translation and cell growth. In conclusion, this work shows that AMPKalpha2 plays a role of brake for the development of cardiac hypertrophy. |
